To cite this article: Maurer M, Weller K, Bindslev‐Jensen C, Giménez‐Arnau A, Bousquet PJ,
Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CEH, Greaves MW, Hide M, …

Leishmaniases remain a major public health problem today despite the vast amount of
research conducted on Leishmania pathogens. The biological model is genetically and …

Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and
middle‐aged women. It usually lasts for several years (> 1 year in 25–75% of patients) and …

This evidence‐ and consensus‐based guideline was developed following the methods
recommended by Cochrane and the Grading of Recommendations Assessment, Development …

This guideline is the result of a systematic literature review using the ‘ G rading of R
ecommendations A ssessment, D evelopment and E valuation’ ( GRADE ) methodology and a …

This update and revision of the international guideline for urticaria was developed following
the methods recommended by Cochrane and the Grading of Recommendations Assessment…

Background Most urticarias are induced by vasoactive mediators such as histamine released
from mast cells. Although mast cells are activated by allergens through cross-linking of cell-…

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline …

Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate
therapy are essential. This update and revision of the global guideline for HAE provides …

Circulating histamine releasing factor(s) have been demonstrated previously in chronic
urticaria by an immediate weal‐and‐flare response to intradermal autologous serum injection. …